Publications by authors named "Mitchell V Mathis"

Claim this Profile
A
Assessment of Similarity in Antipsychotic Exposure-Response Relationships in Clinical Trials Between Adults and Adolescents With Acute Exacerbation of Schizophrenia.
Shamir N Kalaria, Tiffany R Farchione, Mitchell V Mathis, Mathangi Gopalakrishnan, Islam Younis

J Clin Pharmacol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Quantitative Justification of Similarity in Placebo Response Between Adults and Adolescents With Acute Exacerbation of Schizophrenia in Clinical Trials.
Shamir N Kalaria, Hao Zhu, Tiffany R Farchione, Mitchell V Mathis, Mathangi Gopalakrishnan

Clin Pharmacol Ther· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Food and Drug Administration's Approval of Aripiprazole Tablets With Sensor: Our Perspective.
Daniel J Lee, Tiffany R Farchione, Mitchell V Mathis, Javier Muniz, Brendan M Muoio

J Clin Psychiatry· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-response analyses of blood pressure and heart rate changes for methylphenidate in healthy adults.
Liang Li, Yaning Wang, Ramana S Uppoor, Mehul U Mehta, Tiffany Farchione, Mitchell V Mathis

J Pharmacokinet Pharmacodyn· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia.
Michael C Davis, Brian J Miller, Jasmeet K Kalsi, Thomas Birkner, Mitchell V Mathis

N Engl J Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The US Food and Drug Administration's Perspective on the New Antipsychotic Pimavanserin.
Mitchell V Mathis, Brendan M Muoio, Paul Andreason, Amy M Avila, Tiffany Farchione

J Clin Psychiatry· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory and scientific issues in studies to evaluate sexual dysfunction in antidepressant drug trials.
Ni A Khin, Phillip D Kronstein, Peiling Yang, Eiji Ishida, H M James Hung, Mitchell V Mathis

J Clin Psychiatry· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The US Food and Drug Administration's perspective on the new antidepressant vortioxetine.
Jing Zhang, Mitchell V Mathis, Jenn W Sellers, George Kordzakhia, Andre J Jackson

J Clin Psychiatry· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis